These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 26614409)
21. Molecular Docking and 3D Qsar Studies of C000000956 as a Potent Inhibitor of Bace-1. Joseph OA; Babatomiwa K; Niyi A; Olaposi O; Olumide I Drug Res (Stuttg); 2019 Aug; 69(8):451-457. PubMed ID: 30780168 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of 4-aminopyrimidine or 4,6-diaminopyrimidine derivatives as beta amyloid cleaving enzyme-1 inhibitors. Xu X; Lü P; Wang J; Xu F; Liang L; Wang C; Niu Y; Xu P Chem Biol Drug Des; 2019 May; 93(5):926-933. PubMed ID: 30667164 [TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors. Xu YZ; Yuan S; Bowers S; Hom RK; Chan W; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Yan J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR Bioorg Med Chem Lett; 2013 May; 23(10):3075-80. PubMed ID: 23570791 [TBL] [Abstract][Full Text] [Related]
24. In Silico Design of Beta-Secretase Inhibitors in Alzheimer's Disease. Semighini EP Chem Biol Drug Des; 2015 Sep; 86(3):284-90. PubMed ID: 25476252 [TBL] [Abstract][Full Text] [Related]
25. Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates. Zhao XJ; Gong DM; Jiang YR; Guo D; Zhu Y; Deng YC Eur J Med Chem; 2017 Sep; 138():738-747. PubMed ID: 28728106 [TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors. Gabr MT; Abdel-Raziq MS Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870 [TBL] [Abstract][Full Text] [Related]
27. N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation. Edraki N; Firuzi O; Fatahi Y; Mahdavi M; Asadi M; Emami S; Divsalar K; Miri R; Iraji A; Khoshneviszadeh M; Firoozpour L; Shafiee A; Foroumadi A Arch Pharm (Weinheim); 2015 May; 348(5):330-7. PubMed ID: 25787800 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities. De Tran Q; Bepary S; Lee GH; Cho H; Park WK; Lim HJ Bioorg Med Chem Lett; 2016 Jan; 26(1):51-4. PubMed ID: 26608551 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive 3D-QSAR and binding mode of BACE-1 inhibitors using R-group search and molecular docking. Huang D; Liu Y; Shi B; Li Y; Wang G; Liang G J Mol Graph Model; 2013 Sep; 45():65-83. PubMed ID: 24004830 [TBL] [Abstract][Full Text] [Related]
30. Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis. Azimi S; Zonouzi A; Firuzi O; Iraji A; Saeedi M; Mahdavi M; Edraki N Eur J Med Chem; 2017 Sep; 138():729-737. PubMed ID: 28728105 [TBL] [Abstract][Full Text] [Related]
31. From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold. Rampa A; Mancini F; De Simone A; Falchi F; Belluti F; Di Martino RM; Gobbi S; Andrisano V; Tarozzi A; Bartolini M; Cavalli A; Bisi A Bioorg Med Chem Lett; 2015 Jul; 25(14):2804-8. PubMed ID: 26003339 [TBL] [Abstract][Full Text] [Related]
32. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease. Ribaudo G; Coghi P; Zanforlin E; Law BYK; Wu YYJ; Han Y; Qiu AC; Qu YQ; Zagotto G; Wong VKW Bioorg Chem; 2019 Jun; 87():474-483. PubMed ID: 30927588 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological investigation of quinoxaline-bisthiazoles as multitarget-directed ligands for the treatment of Alzheimer's disease. Sagar SR; Singh DP; Das RD; Panchal NB; Sudarsanam V; Nivsarkar M; Vasu KK Bioorg Chem; 2019 Aug; 89():102992. PubMed ID: 31174042 [TBL] [Abstract][Full Text] [Related]
34. Computational methods in the discovery and design of BACE-1 inhibitors. Kacker P; Bottegoni G; Cavalli A Curr Med Chem; 2012; 19(36):6095-111. PubMed ID: 23072352 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1. Marcin LR; Higgins MA; Zusi FC; Zhang Y; Dee MF; Parker MF; Muckelbauer JK; Camac DM; Morin PE; Ramamurthy V; Tebben AJ; Lentz KA; Grace JE; Marcinkeviciene JA; Kopcho LM; Burton CR; Barten DM; Toyn JH; Meredith JE; Albright CF; Bronson JJ; Macor JE; Thompson LA Bioorg Med Chem Lett; 2011 Jan; 21(1):537-41. PubMed ID: 21078556 [TBL] [Abstract][Full Text] [Related]
36. Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies. John S; Thangapandian S; Sakkiah S; Lee KW BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S28. PubMed ID: 21342558 [TBL] [Abstract][Full Text] [Related]